When do you use extended-release buprenorphine instead of daily formulations?

Extended-release buprenorphine (e.g., Sublocade, Brixadi) can be a good option for patients who have trouble staying stable on daily sublingual doses, especially those with adherence challenges, ongoing exposure to high-risk opioids such as fentanyl, or concerns about safety and diversion. Clinical ...

I consider XR-buprenorphine formulations for a variety of patients. When I have a patient with an OUD diagnosis, I inform them about all the FDA-approved treatments and try to help them understand the differences and pros/cons of each of them, as each may pertain to their specific goals and preferen...